Pharmeca.cz

Notification of the Ministry of Health of the Czech Republic against the decision of the State Institute for Drug Control from 7. 1. 2021, under the no. SUKLS312264/2020, regarding the withdrawal of the appeal of the appelant Union of Health Insurance Companies. The decision of the State Institute for Drug Control is valide since 26. 3. 2021.

More information - MZCR.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Allergan Pharmaceuticals Ireland, Ipsen Pharma SAS, against the decision of the State Institute for Drug Control from 31. 12. 2012, under the no. SUKLS203453/2010:

• the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.
  

More information: MZCR.cz.

Notification of the Ministry of Health of the Czech Republic against the decision of the State Institute for Drug Control from 12. 1. 2021, under the no. SUKLS256565/2020, regarding the withdrawal of the appeal of the appelant Merck spol. s r.o. The decision of the State Institute for Drug Control is valide since 10. 3. 2021.

More information - MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of health insurance companies, against the decision of the State Institute for Drug Control from 8. 2. 2019, under the no.: SUKLS285040/2018:

• the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant BAXTER AG, against the decision of the State Institute for Drug Control from 29. 3. 2019, under the no.: SUKLS54097/2019:

• the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.
  

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of health insurance companies, against the decision of the State Institute for Drug Control from 29. 3. 2019, under the no. SUKLS36982/2017:

• under article 90 paragraph 4 in connection with article 66 paragraph 2 of the Administrative Code the operative part 8, 13, 26, 29, 38, 39, 40, 41, 42, 47, 52, 70, 71, 72, 73, 75, 78, 79, 108, 122, 127, 128, 129, 144, 148, 153, 154, 155, 156, 157, 165, 171, 179, 181 and 182 of the decision under appeal is dismissed and the proceedings are terminated,
  
• under article 90 paragraph 5 of the Administrative Code the appeal is dismissed and the rest of the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of health insurance companies, against the decision of the State Institute for Drug Control from 3. 9. 2013, under the no.: SUKLS263719/2012:

• the operative part I, XX, XXI, XXII and XXIII of the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.
  

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of health insurance companies, against the decision of the State Institute for Drug Control from 5. 2. 2019, under the no.: SUKLS202814/2018:

• under article 90 paragraph 4 in connection with article 66 paragraph 1 letter f) of the Administrative Code the operative part 2b) of the decision under appeal is dismissed and the proceedings are terminated,
• under article 90 paragraph 5 of the Administrative Code the appeal is dismissed and the rest of the decision under appeal is upheld.

More information: MZCR.cz.